Journal of Molecular Biomarkers and Clinical Trials
Biomarkers: Towards the Dream of Personalized Medicine
*Dr. Sebastiano Cavallaro Department Of Molecular Biomarkers, Institute Of Neurological Sciences, Italy
*Corresponding Author: Dr. Sebastiano Cavallaro
Department Of Molecular Biomarkers, Institute Of Neurological Sciences, Italy Email:firstname.lastname@example.org
Published on: 2015-12-10
Since the completion of the Human Genome Project in the early 2000’s, genome-wide high-throughput technologies have transformed the biomedical research field. The growing quantity of information produced is collected in specific public repositories and is available for the scientific community, however only few of this “OMICS” information have been transferred to the patient bedside.
Biomarkers, Molecular taxonomy for diagnosis, pathophysiological mechanisms
We have every reason to expect that the evolution of molecular medicine, coupled with the discovery and clinical application of new biomarkers, will continue to advance in this field, where individualized and customized treatment for each individual patient will define the standard of care. However, we are still far from being able to use profitably all the information already available to us. New integrated and easy-to-use technologies are in developing in order to move omics biomarkers-based data analysis to the bedside. To facilitate the growth of this rapidly developing multidisciplinary field, and to promote the implementation of new technologies able to offer qualitative and quantitative multi-biomarkers analysis, Jacobs Journal of Biomarkers aims to facilitate a rapid dissemination and exchange of scientific advances about all aspects of biomarkers applications in various biomedical disciplines.